Fidelity International’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-500
Closed -$17K 813
2019
Q4
$17K Buy
+500
New +$18.1K ﹤0.01% 731
2019
Q3
Sell
-126,594
Closed -$5.52M 891
2019
Q2
$5.52M Sell
126,594
-8,271
-6% -$354K 0.01% 522
2019
Q1
$5.76M Buy
134,865
+40,658
+43% +$1.82M 0.01% 499
2018
Q4
$4.22M Buy
+94,207
New +$4.94M 0.01% 525
2018
Q3
Sell
-56,528
Closed -$3.24M 926
2018
Q2
$3.24M Sell
56,528
-3,094
-5% -$163K ﹤0.01% 579
2018
Q1
$2.75M Buy
59,622
+12,798
+27% +$608K 0.01% 432
2017
Q4
$2.16M Buy
+46,824
New +$2.15M 0.01% 457

Other funds holding AVNS

Fidelity International's AVNS Position: Q1 2020 in Review

Fidelity International sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 500 shares — an estimated $17K sold.

Fidelity International first reported a position in AVNS in Q4 2017 and held it in 7 quarters. The position peaked at $5.76M in Q1 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Fidelity International reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Fidelity International sold 500 Avanos Medical shares in Q1 2020, an estimated $17K.
  • Fidelity International first reported a position in Avanos Medical in Q4 2017 and held it in 7 quarters.
  • Fidelity International's Avanos Medical position peaked at $5.76M in Q1 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Fidelity International's 13F filing for Q1 2020, filed 14 May 2020.